Shopping Cart
- Remove All
- Your shopping cart is currently empty
Urelumab(BMS-66513) is a humanized IgG4 monoclonal antibody, often used as a CD137 agonist.Urelumab has potential antitumor activity, potentiating tumor cell killing by T-cells and natural killer cells, and enhancing the cytotoxicity of Rituximab.Urelumab has been used in the study of solid tumor-related diseases such as diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL). Urelumab can be used to study diseases associated with solid tumors such as diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $528 | In Stock | |
5 mg | $1,570 | In Stock | |
10 mg | $2,130 | In Stock | |
25 mg | $3,160 | In Stock | |
50 mg | $4,270 | In Stock | |
100 mg | $5,760 | In Stock |
Description | Urelumab(BMS-66513) is a humanized IgG4 monoclonal antibody, often used as a CD137 agonist.Urelumab has potential antitumor activity, potentiating tumor cell killing by T-cells and natural killer cells, and enhancing the cytotoxicity of Rituximab.Urelumab has been used in the study of solid tumor-related diseases such as diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL). Urelumab can be used to study diseases associated with solid tumors such as diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL). |
Alias | BMS-66513, BMS-663513 |
Molecular Weight | 145.90 kDa |
Cas No. | 934823-49-1 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.